Business Context and Reporting Period
Company: DaVita Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: July 28, 2005
Reporting Period: This filing announces financial results for the quarter and six months ended June 30, 2005. The report references the company's most recent Form 10-Q (ended March 31, 2005) and Form 10-K (ended December 31, 2004).
Key Financial Metrics
The Form 8-K text itself does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These figures are contained within the attached press release (Exhibit 99.1), which is referenced but not included in the provided text.
The filing highlights the use of the following non-GAAP financial measures to supplement GAAP results:
- Operating cash flows and free cash flows (excluding after-tax benefits of Medicare lab recoveries for prior period services and tax benefits from stock option exercises).
- Operating income excluding Medicare lab recoveries related to prior period services.
- Total operating revenue excluding Medicare lab recoveries related to prior period services.
- Consolidated EBITDA (as defined in senior notes indentures) for calculating debt leverage ratios.
Material Changes
The filing text does not provide specific data on material changes versus prior periods. It notes that the company historically reports non-GAAP measures to exclude non-recurring expenses and Medicare lab recoveries, which can cause unusual fluctuations in operating performance. The purpose of these measures is to provide consistency and comparability to prior periods.
Guidance, Outlook, and Risks
Forward-Looking Statements: The attached press release contains forward-looking statements regarding performance for 2005 and 2006. The company states these are based on currently available information and involves substantial known and unknown risks.
Risks and Uncertainties: Actual results could differ materially from those described due to risks and uncertainties. The company explicitly states it undertakes no obligation to update or revise these forward-looking statements.
Regulatory Context: The filing includes disclosures regarding Regulation G compliance for non-GAAP measures and notes that reconciliations to GAAP measures are included in the attached press release.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated July 28, 2005) for specific GAAP and non-GAAP financial figures for the quarter and six months ended June 30, 2005.
- Verify the reconciliation of non-GAAP measures (EBITDA, free cash flow, operating income) to their most directly comparable GAAP measures as required by Regulation G.
- Examine the specific forward-looking guidance for 2005 and 2006 provided in the press release.
- Assess the impact of Medicare lab recoveries related to prior period services on reported operating results.
- Confirm compliance with financial covenants in the senior notes indentures and senior secured credit agreement using the reported EBITDA figures.